[TCT2008]克利夫兰的一名医生被授予“青年医师研究奖”
发布于:2008-10-17 09:59
Cleveland Clinic Fellow Receives Young Investigator Award
最近,他在JACC上发表了一篇文章,比较DES和BMS的长期疗效及危险因素;在Cleveland Clinic Journal of Medicine 发表了一篇关于经皮治疗钙化性主动脉狭窄,在AHA上发表了一篇PES和SES长期安全性和有效性分析。
其他参加奖项角逐的还有血管内神经外科医生J. Mocco,介入医生Dr. Martijn Meuwissen。
(《医心评论》编辑 马秀芹 翻译 刘瑞琦 校对)
(来源:www.tctmd.com)
Cleveland Clinic Fellow Receives Young Investigator Award
Key Points:
By TCT Daily Staff
At the 20th anniversary of the TCT symposium Research Foundation presented Mehdi H. Shishehbor, DO, MPH, PhD, with the Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award.
This award acknowledges clinical and academic distinction in interventional vascular medicine and honors the memory of Thomas J. Linnemeier, MD, the former chief of the Indiana Heart Institute, senior vice president of New Ventures, and chief medical officer of Vascular Intervention at Guidant Corp.
The award encourages continued commitment and dedication to both patient care and academic research and includes a $10,000 scholarship.
"I am honored to be recognized by the leaders of interventional cardiology for the Thomas J. Linnemeier Spirit of Interventional Cardiology," Shishehbor said.
"This is an important award that recognizes not only academic achievement but also clinical skills."
Research interests, recent publications
Shishehbor’s research interests include three areas of coronary artery disease: the role of inflammation and oxidation in atherogenesis; the impact of DES versus BMS for treating various patients and lesions; and the role of socioeconomic status and contextual factors on cardiovascular disease and physiology.
Recent publications have included articles in the Journal of the American College of Cardiology comparing the long-term impact of DES vs. bare-metal stents and emerging cardiovascular risk factors; in the Cleveland Clinic Journal of Medicine on percutaneous treatment of calcific aortic stenosis; and in the American Heart Journal on the safety and efficacy of overlapping sirolimus-eluting stents vs. paclitaxel-eluting stents.
Shishehbor is co-author of the emergency manual Management of Patients in Cardiac Intensive Care Units (Lippincott Williams & Wilkins), and has authored chapters for clinical textbooks on inflammatory markers in acute coronary syndromes, mitral and tricuspid valve disease, and imaging for intracardiac procedures.
Collaborations and committment
Shishehbor, who is an interventional cardiology fellow in the department of cardiovascular medicine at the Cleveland Clinic in Ohio, has collaborated with colleagues from other institutions such as Case Western Reserve University, Duke University, the University of Alabama, and the University of Washington.
"I am very happy and excited about this award and hope to use this achievement to fuel my commitment in becoming an excellent clinical and academic interventional cardiologist," Shishehbor said.
The other finalists for the award were J. Mocco, MD, MS, a fellow in endovascular neurosurgery from the University at Buffalo in New York, and Martijn Meuwissen, MD, a fellow in interventional cardiology at the Academic Medical Center at the University of Amsterdam in The Netherlands.
(source:www.tctmd.com)
在庆祝TCT20年的纪念会上,基金会为Mehdi H. Shishehbor颁发了“青年医师研究奖”。该奖项设置目的主要是用于表彰在临床和科研领域作出突出贡献的专家学者,也是为了缅怀Dr.Thomas J. Linnemeier——前印第安纳州心血管病研究所所长,New Ventures副主席和Guidant Corp心血管介入部首席医疗顾问。获得该称号的患者还可以赢得$10,000奖学金。
“我非常荣幸能够拿到这个奖,因为它是对我学术成就和临床技能的认可,”Shishehbor说。
研究领域及最新发表的文章
Shishehbor的研究主要集中在冠脉疾病的3个领域:炎症和氧化在动脉粥样硬化形成过程中的作用;不同病变以及不同患者应用DES和BMS之间的对比研究;社会经济地位在冠心病及其生理机制形成过程中的作用。
他还是《监护病房患者治疗手册》的第二作者,并且还参与了ACS 炎症标记物、二尖瓣和三尖瓣疾病治疗和心内科影像技术操作等临床工具书的部分章节的撰写工作。
合作与交流
作为一名介入医生,Shishehbor经常与其他医院如Case Western Reserve大学、Duke大学、Case Western Reserve大学和华盛顿大学研究所的同道进行学术交流,
“我非常高兴也非常兴奋能够赢得这个大奖,我希望我今天所取得的成就能够点燃我的人生信念——成为一名在临床及研究方面优秀的介入心脏病学专家。”Shishehbor说。
来源: 医心网



京公网安备 11010102002968号